Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease

Background Atrial fibrillation (AF) frequently occurs in patients with chronic kidney disease (CKD); however, the long‐term impact of development of AF on the risk of death among patients with CKD is unknown. Methods and Results We studied adults with CKD (glomerular filtration rate <60 mL/min per 1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration equation) identified between 2002 and 2010 who were enrolled in Kaiser Permanente Northern California and had no previously documented AF. Incident AF was identified using primary hospital discharge diagnoses or ≥2 outpatient visits for AF. Death was comprehensively ascertained from health plan administrative databases, Social Security Administration vital status files, and the California death certificate registry. Covariates included demographics, comorbidity, ambulatory blood pressure, laboratory values (hemoglobin, proteinuria), and longitudinal medication use. Among 81 088 adults with CKD, 6269 (7.7%) developed clinically recognized incident AF during a mean follow‐up of 4.8±2.7 years. There were 2388 cases of death that occurred after incident AF (145 per 1000 person‐years) compared with 18 865 cases of death during periods without AF (51 per 1000 person‐years, P<0.001). After adjustment for potential confounders, incident AF was associated with a 66% increase in relative rate of death (adjusted hazard ratio 1.66, 95% CI 1.57 to 1.77). Conclusion Incident AF is independently associated with an increased risk of death in adults with CKD. Further study is needed to understand the mechanisms by which CKD is associated with AF and to identify potentially modifiable risk factors to decrease the burden of AF and subsequent risk of death in this high‐risk population.

[1]  T. Dawber,et al.  The Framingham Study , 2014 .

[2]  Talicia A Tarver HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[3]  S. Yusuf,et al.  Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.

[4]  G. Marcus,et al.  Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults With Chronic Kidney Disease , 2013, Circulation.

[5]  M. Joffe,et al.  Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[6]  J. Spertus,et al.  The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients. , 2012, Kidney international.

[7]  R. Asinger,et al.  Warfarin in atrial fibrillation patients with moderate chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[8]  S. Baldus,et al.  Inflammatory pathways underlying atrial fibrillation. , 2011, Trends in molecular medicine.

[9]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[10]  Josef Coresh,et al.  Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[11]  Kortaro Tanaka,et al.  Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. , 2011, The American journal of cardiology.

[12]  E. Benjamin,et al.  Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Elsayed Z Soliman,et al.  Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2011, Circulation. Arrhythmia and electrophysiology.

[14]  W. Winkelmayer,et al.  The increasing prevalence of atrial fibrillation among hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.

[15]  S. Dudley,et al.  Atrial fibrillation: the emerging role of inflammation and oxidative stress. , 2010, Cardiovascular & hematological disorders drug targets.

[16]  C. Herzog,et al.  Abstract 18013: Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients , 2010 .

[17]  Satoko Nakamura,et al.  Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients , 2010, Journal of hypertension.

[18]  P. Kerr,et al.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.

[19]  A. Go,et al.  Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). , 2010, American heart journal.

[20]  E. Lerma,et al.  Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[21]  A. Folsom,et al.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.

[22]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[23]  C. McCulloch,et al.  Risk factors for end-stage renal disease: 25-year follow-up. , 2009, Archives of internal medicine.

[24]  S. Iravanian,et al.  The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. , 2008, Heart rhythm.

[25]  Maria Grazia Valsecchi,et al.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  Melissa M. Parker,et al.  Glycemic response to newly initiated diabetes therapies. , 2007, The American journal of managed care.

[27]  A. Go,et al.  Statin therapy and risks for death and hospitalization in chronic heart failure. , 2006, JAMA.

[28]  E. Maltezos,et al.  Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. , 2006, The American journal of cardiology.

[29]  J. Langberg,et al.  Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage: Role of the NADPH and Xanthine Oxidases , 2005, Circulation.

[30]  G. Beck,et al.  C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. , 2005, Kidney international.

[31]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[32]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[33]  B. Psaty,et al.  Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.

[34]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[35]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[36]  J. Selby,et al.  Evaluating hypertension control in a managed care setting. , 1999, Archives of internal medicine.

[37]  M A Waclawiw,et al.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[38]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[39]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[40]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[41]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.